These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27340862)

  • 1. The number of tumorspheres cultured from peripheral blood is a predictor for presence of metastasis in patients with breast cancer.
    Pizon M; Schott D; Pachmann U; Pachmann K
    Oncotarget; 2016 Jul; 7(30):48143-48154. PubMed ID: 27340862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of adjuvant radiotherapy on circulating epithelial tumor cells and circulating cancer stem cells in primary non-metastatic breast cancer.
    Schott DS; Pizon M; Pachmann U; Pachmann K; Schobert R; Wittig A; Mäurer M
    Transl Oncol; 2021 Mar; 14(3):101009. PubMed ID: 33453469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B7-H3 on circulating epithelial tumor cells correlates with the proliferation marker, Ki-67, and may be associated with the aggressiveness of tumors in breast cancer patients.
    Pizon M; Schott DS; Pachmann U; Pachmann K
    Int J Oncol; 2018 Nov; 53(5):2289-2299. PubMed ID: 30226585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor receptor I (IGF-IR) and vascular endothelial growth factor receptor 2 (VEGFR-2) are expressed on the circulating epithelial tumor cells of breast cancer patients.
    Pizon M; Zimon DS; Pachmann U; Pachmann K
    PLoS One; 2013; 8(2):e56836. PubMed ID: 23418605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of endocrine therapy on the ratio of androgen receptor (AR) to estrogen receptor (ER) positive circulating epithelial tumor cells (CETCs) in breast cancer.
    Pizon M; Lux D; Pachmann U; Pachmann K; Schott D
    J Transl Med; 2018 Dec; 16(1):356. PubMed ID: 30547831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse.
    Pachmann K; Camara O; Kavallaris A; Krauspe S; Malarski N; Gajda M; Kroll T; Jörke C; Hammer U; Altendorf-Hofmann A; Rabenstein C; Pachmann U; Runnebaum I; Höffken K
    J Clin Oncol; 2008 Mar; 26(8):1208-15. PubMed ID: 18323545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of circulating epithelial tumor cells using the Maintrac
    Gold M; Pachmann K; Kiani A; Schobert R
    Mol Clin Oncol; 2021 Oct; 15(4):201. PubMed ID: 34462657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cancer stem cell model for studying brain metastases from primary lung cancer.
    Nolte SM; Venugopal C; McFarlane N; Morozova O; Hallett RM; O'Farrell E; Manoranjan B; Murty NK; Klurfan P; Kachur E; Provias JP; Farrokhyar F; Hassell JA; Marra M; Singh SK
    J Natl Cancer Inst; 2013 Apr; 105(8):551-62. PubMed ID: 23418195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The isolation and characterization of CTC subsets related to breast cancer dormancy.
    Vishnoi M; Peddibhotla S; Yin W; T Scamardo A; George GC; Hong DS; Marchetti D
    Sci Rep; 2015 Dec; 5():17533. PubMed ID: 26631983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of suspension array assay to detect marker genes expression of circulating tumor cells for early prediction of breast cancer metastasis].
    Ke F; Wu JM; Yao JE; Bai YJ; Guo AL
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2257-61. PubMed ID: 18001545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitive detection of PD-L1 expression on circulating epithelial tumor cells (CETCs) could be a potential biomarker to select patients for treatment with PD-1/PD-L1 inhibitors in early and metastatic solid tumors.
    Schott DS; Pizon M; Pachmann U; Pachmann K
    Oncotarget; 2017 Sep; 8(42):72755-72772. PubMed ID: 29069824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
    Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
    J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of circulating tumor cells in breast cancer patients.
    Tao M; Ma D; Li Y; Zhou C; Li Y; Zhang Y; Duan W; Xu X; Wang R; Wu L; Liu H
    Breast Cancer Res Treat; 2011 Aug; 129(1):247-54. PubMed ID: 21512769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcripts of circulating tumor cells detected by a breast cancer-specific platform correlate with clinical stage in bladder cancer patients.
    Todenhöfer T; Hennenlotter J; Dorner N; Kühs U; Aufderklamm S; Rausch S; Bier S; Mischinger J; Schellbach D; Hauch S; Feniuk N; Bedke J; Gakis G; Stenzl A; Schwentner C
    J Cancer Res Clin Oncol; 2016 May; 142(5):1013-20. PubMed ID: 26910601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer.
    Ueo H; Sugimachi K; Gorges TM; Bartkowiak K; Yokobori T; Müller V; Shinden Y; Ueda M; Ueo H; Mori M; Kuwano H; Maehara Y; Ohno S; Pantel K; Mimori K
    Br J Cancer; 2015 Apr; 112(9):1519-26. PubMed ID: 25880010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating epithelial tumor cells as a prognostic tool for malignant melanoma.
    Pachmann K; Willecke-Hochmuth R; Schneider K; Kaatz M
    Melanoma Res; 2018 Feb; 28(1):37-43. PubMed ID: 29076925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients.
    Soria JC; Gauthier LR; Raymond E; Granotier C; Morat L; Armand JP; Boussin FD; Sabatier L
    Clin Cancer Res; 1999 May; 5(5):971-5. PubMed ID: 10353728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients.
    Wong NS; Kahn HJ; Zhang L; Oldfield S; Yang LY; Marks A; Trudeau ME
    Breast Cancer Res Treat; 2006 Sep; 99(1):63-9. PubMed ID: 16541316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.